Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,122.62
(
0.83%
)
US TECH 100
26,080.80
(
1.19%
)
Dow Jones
49,509.60
(
0.13%
)
Brent Oil
96.56
(
1.63%
)
Bitcoin
78,874.35
(
3.34%
)
News Focus
News Focus
Post# of 257437
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

db7

Send PM Follow Ignore
Followers 219
Posts 39820
Boards Moderated 0
Alias Born 09/02/2003

db7

Member Level

Re: dewophile post# 247704

Friday, 11/15/2024 11:06:51 AM

Friday, November 15, 2024 11:06:51 AM

Post# of 257437
ABUS AASLD "50% of patients who had baseline HBsAg levels less than 1000 IU/mL achieved functional cure in Cohort A1 of the IM-PROVE I Phase 2a clinical trial

Overall, in Cohort A1, 25% of patients achieved functional cure" https://investor.arbutusbio.com/news-releases/news-release-details/arbutus-imdusiran-achieves-functional-cure-chbv-patients-when

-------------------------------------------------------------------

All posts are strictly my opinion and are not buy or sell recommendations.

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today